AstraZeneca Pharma India Ltd - 506820 - Intimation About Second Brand Partnership Between Astrazeneca Pharma India Limited ("Company") And Sun Pharmaceuticals Industries Limited For Sodium Zirconium Cyclosilicate Powder For Oral Suspension 5 G

AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 | Industry: Pharmaceuticals
| Expensive Performer

9035.0000 -105.00 (-1.15%)

NSE Nov 18, 2025 15:29 PM

Volume: 27,913

AstraZeneca Pharma India Ltd.

17 Nov 2025, 03:40PM

9035.00

-1.15%

Company Update

BSE India

Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.